Cargando…
Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
Parkinson’s disease (PD), characterized by dopaminergic neuron degeneration in the substantia nigra and dopamine depletion in the striatum, affects up to 1% of the global population over 50 years of age. Our previous study found that a heteropolysaccharide from Saccharina japonica exhibits neuroprot...
Autores principales: | Liu, Yingjuan, Jin, Weihua, Deng, Zhenzhen, Wang, Jing, Zhang, Quanbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551172/ https://www.ncbi.nlm.nih.gov/pubmed/32842556 http://dx.doi.org/10.3390/md18090438 |
Ejemplares similares
-
Glucuronomannan GM2 from Saccharina japonica Enhanced Mitochondrial Function and Autophagy in a Parkinson’s Model
por: Liu, Yingjuan, et al.
Publicado: (2021) -
Structural Features of Sulfated Glucuronomannan Oligosaccharides and Their Antioxidant Activity
por: Jin, Weihua, et al.
Publicado: (2018) -
Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
por: Hong, Dong Geun, et al.
Publicado: (2022) -
GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023) -
Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)